Werewolf Therapeutics (HOWL) Operating Leases (2020 - 2026)
Werewolf Therapeutics (HOWL) posted quarterly Operating Leases of $7.2 million for Q1 2026, down 19.97% year-over-year from $9.0 million in Q1 2025, and down 6.09% on a QoQ basis from $7.7 million in Q4 2025.
Werewolf Therapeutics (HOWL) Operating Leases (2020 - 2026) Analysis & Trends
Werewolf Therapeutics has reported Operating Leases for 7 years, with the latest figure at $7.2 million in Q1 2026.
- Operating Leases for Q1 2026 came in at $7.2 million, down 19.97% year-over-year; the trailing twelve-month figure through Mar 2026 was $7.2 million (down 19.97% YoY), and the FY2025 annual result was $7.7 million, down 18.56% from the prior year.
- Operating Leases retreated to $7.2 million in Q1 2026, from $7.7 million in the prior quarter.
- Over five years, Operating Leases peaked at $15.5 million in Q2 2022 and troughed at $7.2 million in Q1 2026.
- A 5-year average of $10.9 million and a median of $10.6 million in 2024 frame the typical range for Operating Leases.
- The widest annual swing landed in 2022, when Operating Leases soared 1069.08%; it then decreased 25.13% in 2023.
- A 5-year view of Operating Leases shows it stood at $12.6 million in 2022, then decreased by 12.76% to $11.0 million in 2023, then dropped by 14.16% to $9.4 million in 2024, then declined by 18.56% to $7.7 million in 2025, then retreated by 6.09% to $7.2 million in 2026.
- Per Business Quant data, the three most recent Operating Leases figures were $7.2 million in Q1 2026, $7.7 million in Q4 2025, and $8.1 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - |
| 10 | Werewolf Therapeutics | 43.94 Mn | 43.94 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 7.22 Mn |
| Dec 31, 2025 | 7.68 Mn |
| Sep 30, 2025 | 8.14 Mn |
| Jun 30, 2025 | 8.59 Mn |
| Mar 31, 2025 | 9.02 Mn |
| Dec 31, 2024 | 9.44 Mn |
| Sep 30, 2024 | 9.84 Mn |
| Jun 30, 2024 | 10.24 Mn |
| Mar 31, 2024 | 10.62 Mn |
| Dec 31, 2023 | 10.99 Mn |
| Sep 30, 2023 | 11.35 Mn |
| Jun 30, 2023 | 11.71 Mn |
| Mar 31, 2023 | 12.04 Mn |
| Dec 31, 2022 | 12.60 Mn |
| Sep 30, 2022 | 15.16 Mn |
| Jun 30, 2022 | 15.55 Mn |
| Mar 31, 2022 | 14.29 Mn |
| Dec 31, 2021 | 14.59 Mn |
| Sep 30, 2021 | 1.30 Mn |
| Jun 30, 2021 | 1.49 Mn |